GeneDx Holdings (WGS) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$0.27.
- GeneDx Holdings' EPS (Weighted Average and Diluted) rose 1290.32% to -$0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.09, marking a year-over-year increase of 10289.39%. This contributed to the annual value of -$1.94 for FY2024, which is 7310.72% up from last year.
- Latest data reveals that GeneDx Holdings reported EPS (Weighted Average and Diluted) of -$0.27 as of Q3 2025, which was up 1290.32% from $0.36 recorded in Q2 2025.
- GeneDx Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.98 during Q4 2021, with a 5-year trough of -$348.82 in Q1 2021.
- In the last 5 years, GeneDx Holdings' EPS (Weighted Average and Diluted) had a median value of -$1.1 in 2024 and averaged -$23.88.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 430000.0% in 2022, then skyrocketed by 13272.73% in 2025.
- Over the past 5 years, GeneDx Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $0.98 in 2021, then tumbled by 3056.12% to -$28.97 in 2022, then surged by 96.82% to -$0.92 in 2023, then soared by 121.98% to $0.2 in 2024, then plummeted by 233.52% to -$0.27 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.27 for Q3 2025, versus $0.36 for Q2 2025 and -$0.23 for Q1 2025.